Inhibitor of inflammatory conditions

A method of treating a disorder or condition selected from the group consisting of:

• psoriasis, demyelinating neurological disorders including multiple sclerosis, all forms of muscular dystrophy, sepsis, sepsis syndrome, osteoporosis, ischemic injury, graft vs. host disease, reperfusion injury, asthma, diabetes, cancer, myelogenous and other leukemias, cachexia, Alzheimer's Disease, acetylcholinesterase mediated disorders, retinal disorders, neurological disorders, muscular disorders, and a combination thereof in a patient in need thereof, comprising administering to said patient:
• a. an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids;
• b. a composition comprising an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids;
• or
• c. a combination therapeutic comprising:
• i.) an effective amount of an alcohol extract of Boswellia frereana, wherein said extract comprises epi-lupeol or a salt thereof, and wherein the extract is devoid of boswellic acids;
• and
• ii.) an additional therapeutic.